Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates
NCT ID: NCT04118400
Last Updated: 2020-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2019-10-31
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants
NCT01624012
Breathing Variability and NAVA in Neonates
NCT04000568
Work of Breathing During Non-invasive Ventilation in Premature Neonates
NCT02788110
NHFOV vs. NCPAP as a Primary Treatment to Neonatal Respiratory Distress Syndrome(NRDS)
NCT03099694
Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates
NCT02064712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental: NIN-NAVA
* Premature\>30weeks with respiratory distress
* PI to determine eligibility or exclusion
* Randomize to either NIV-NAVA or Nasal CPAP (NIMV) 1:1 randomization
* PI will not be blinded to the intervention (not feasible)
* Place the catheter to optimize position
* ABG or VBG to be obtained at 2 hrs. post NIV-NAVA
* NIV-NAVA settings will be weaned or increased as the clinical situation demands and outlined in the protocol
NIV-NAVA
NAVA mode during Non-invasive ventilation
Active Comparator: Nasal CPAP or NIMV
* Premature\>30weeks with respiratory distress
* PI to determine eligibility or exclusion
* Randomize to either NIV-NAVA or Nasal CPAP (NIMV) 1:1 randomization
* PI will not be blinded to the intervention (not feasible)
* Place the catheter to optimize position
* ABG or VBG to be obtained at 2 hrs. post Nasal CPAP or NIMV
* NCPAP or NIMV settings will be weaned or increased as the clinical situation demands and outlined in the protocol
Nasal CPAP or NIMV mode
Nasal CPAP or NIMV mode during Non-invasive ventilation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIV-NAVA
NAVA mode during Non-invasive ventilation
Nasal CPAP or NIMV mode
Nasal CPAP or NIMV mode during Non-invasive ventilation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Respiratory distress
Exclusion Criteria
2. ENT contraindication: fistula
3. Contraindication with orogastric tube or nasogastric
30 Weeks
37 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hsin-yu LI
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University Hospital, Taiwan, R.O.C
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hsin-yu LI
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N201907028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.